Cyclacel Pharmaceuticals Inc (FRA:UXI)
€ 3.257 0 (0%) Market Cap: 2.86 Mil Enterprise Value: 302,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Cyclacel Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript

Dec 08, 2023 / 02:30PM GMT
Release Date Price: €3.03 (+0.75%)
Paul Mcbarron
Cyclacel Pharmaceuticals Inc - CFO, Board Member

Good morning. Welcome to the Special Meeting of Stockholders of Xcel Pharmaceuticals, Inc. I am Paul McBarron , Executive Vice President, Finance, Chief Financial Officer and Chief Operating Officer of the Company and it is my pleasure to welcome all of you. It is 9:30 A.M. Eastern time. And in accordance with the notice of the meeting, I call to order the Special Meeting of Stockholders of psych sell Pharmaceuticals, Inc.

We have chosen to have this meeting virtually in order to improve our stockholders access to this meeting. And this technology also enables us to contain costs for us and our stockholders. It is our intention to conduct this meeting in accordance with this agenda.

The agenda is currently shown on your screen or available for review in the Meeting Materials section of the meeting website. You will note that under item seven in the agenda, an opportunity is provided at the end of the meeting for general questions and discussion, please adhere to the rules for conduct attached to your agenda in asking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot